Imposter syndrome in academic libraries: Indigenous women edition

This is a written proceeding of the LACUNY 2022 panel presentation “Imposter Syndrome in Academic Libraries: Indigenous Women Edition”. The authors discuss personal instances and feelings of the imposter phenomenon (also known as imposter syndrome) as it may relate to their Indigenous identities. Additionally, the authors describe how imposter syndrome may affect their ability to be successful in their careers, and the internal pressure they feel to present a more Indigenous identity (whatever that may entail) for scholarship and positions. The authors also share their experiences with external pressures to exhibit a more “stereotypical Indigenous” appearance for the sake of their role as Indigenous library staff members, peers, or when applying for academic opportunities and how this relates when interacting with other Indigenous people through their work. They speak on the recent developments in academia in terms of hiring Indigenous peoples and avoiding pretendians (people who falsely claim to have Indigenous ancestry). The goal of the authors is to encourage discourse in the vein of Truth and Reconciliation and spreading awareness about imposter syndrome

December 1998

Editor/Production Manager: Rochelle Bews, Layout & Design: Tennille Smith and Felicity Hammond, Literary: Emma Stanley, Sales: Michelle Smilek, Staff Advisor: Chris Frahm. Printed in Australia.https://research.avondale.edu.au/jacaranda/1043/thumbnail.jp

The novel use of Sentimag to localise metallic foreign bodies in soft tissue

No abstract available

Renal Insufficiency and Early Bystander CPR Predict In-Hospital Outcomes in Cardiac Arrest Patients Undergoing Mild Therapeutic Hypothermia and Cardiac Catheterization: Return of Spontaneous Circulation, Cooling, and Catheterization Registry (ROSCCC Registry)

Objective. Out of hospital cardiac arrest (OHCA) patients are a critically ill patient population with high mortality. Combining mild therapeutic hypothermia (MTH) with early coronary intervention may improve outcomes in this population. The aim of this study was to evaluate predictors of mortality in OHCA patients undergoing MTH with and without cardiac catheterization. Design. A retrospective cohort of OHCA patients who underwent MTH with catheterization (MTH + C) and without catheterization (MTH + NC) between 2006 and 2011 was analyzed at a single tertiary care centre. Predictors of in-hospital mortality and neurologic outcome were determined. Results. The study population included 176 patients who underwent MTH for OHCA. A total of 66 patients underwent cardiac catheterization (MTH + C) and 110 patients did not undergo cardiac catheterization (MTH + NC). Immediate bystander CPR occurred in approximately half of the total population. In the MTH + C and MTH + NC groups, the in-hospital mortality was 48% and 78%, respectively. The only independent predictor of in-hospital mortality for patients with MTH + C, after multivariate analysis, was baseline renal insufficiency (OR = 8.2, 95% CI 1.8–47.1, and p = 0.009). Conclusion. Despite early cardiac catheterization, renal insufficiency and the absence of immediate CPR are potent predictors of death and poor neurologic outcome in patients with OHCA

The introduction of Magtrace® lymphatic tracer for axillary sentinel node biopsy for breast cancer in a rural Scottish district general hospital: initial experience, perspectives, outcomes and learning curves

Background: Magtrace® is a supraparamagnetic iron lymphatic tracer that has had increasing use in sentinel node biopsy (SNB) for breast cancer and has theoretical logistical benefits in centres where nanocolloid use may be associated with such issues. We describe our initial experience with the introduction of Magtrace® into our routine practice by dual localisation with nanocolloid, comparing performance and concordance. Methods: This was prospective study of the first patients undergoing axillary SNB using Magtrace® in a single centre. These patients had dual localisation with nanocolloid and Magtrace®. Subjective global assessments of Magtrace® and nanocolloid performance as well as objective signal strength and anatomical concordance were compared across multiple timepoints in the operative journey. Results: A total of 30 consecutive patients underwent SNB within the timeframe of this study. While there were no failed SNB, 8 issues were reported including 4 issues of perceived imperfect localisation on global assessment. No patient had a failed or abandoned SNB, and only one case had a potential challenge in subsequent management after histopathological examination of the retrieved nodes. The majority of these issues occurred in the first half of the study period. There was overall weak to moderate positive correlation between Magtrace® and nanocolloid signals of the retrieved sentinel nodes (ρ= 0.392,p=0.043). Conclusions: This study suggests that introducing Magtrace was feasible and safe in the context of a rural breast cancer service. A possible strategy to ameliorate the learning curve associated with these procedures is the routine dual localisation in the initial phases of performing Magtrace localisation. Microabstract: Magtrace® is a supraparamagnetic iron lymphatic tracer that has had increasing use in sentinel node biopsy (SNB) for breast cancer. We describe our initial experience with the introduction of Magtrace® into our routine practice by dual localisation with nanocolloid, comparing performance and concordance. We report this as a safe way of introducing its use and ameliorating the learning curve associated with this new technique